Latest News about BMY
Recent news which mentions BMY
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
September 16, 2021
From Benzinga
7 Stocks to Buy to Invest Like Jim Cramer
September 16, 2021
From InvestorPlace
Is AbbVie's 4.9% Dividend Yield Safe?
September 15, 2021
From Motley Fool
Investing in These 2 Top Stocks Could Make You Richer Over the Next 10 Years
September 15, 2021
From Motley Fool
7 Stocks to Buy if the Market Crashes in September
September 13, 2021
From InvestorPlace
Bristol Myers' Immunotherapy Combo Shows Durable Survival At Three Years In MPM Setting
September 13, 2021
Tickers
BMY
From Benzinga
2 Top Biotech Stocks to Buy Right Now
September 11, 2021
From Motley Fool
Here's a Great Reason to Buy Pfizer Stock (and It Has Nothing to Do With the COVID Vaccine)
September 11, 2021
From Motley Fool
8 Health Care Stocks With Unusual Options Alerts In Today's Session
September 10, 2021
From Benzinga
Could This Be Pfizer's Next Blockbuster Vaccine?
September 10, 2021
From Motley Fool
7 Stocks To Buy To Bet on Underappreciated CEOs
September 10, 2021
From InvestorPlace
3 High-Growth Healthcare Stocks to Buy in September
September 09, 2021
From Motley Fool
'Fast Money Halftime Report' Picks For September 8
September 08, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
September 05, 2021
From Benzinga
Wall Street Crime And Punishment: Martha Stewart's Perfectly Ridiculous Stock Scandal
September 03, 2021
From Benzinga
14 dividend stocks from a winning value manager as the broader market hits record highs
September 03, 2021
From MarketWatch
From Benzinga
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
4 Specialized AI Stocks to Buy for the Boom
August 31, 2021
From InvestorPlace
If you’ve got the stock market jitters, here are 20 companies in two defensive sectors
August 30, 2021
From MarketWatch
From Benzinga
5 No-Brainer Stocks to Invest $400 in Right Now
August 30, 2021
From Motley Fool
Why Clovis Oncology Shares Got a Bump This Week
August 27, 2021
From Motley Fool
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.